Bending Spoons Files for U.S. IPO, Italian Acquirer Expands
The Milan-based Italian acquirer, known for reviving fading apps, has filed for a U.S. IPO, revealing sharp revenue g...
Wash-sale considerations when replacing dividend ETF protect your tax position. This guide outlines rule basics, look-back periods, and compliant practices.
13,645 articlesThe Milan-based Italian acquirer, known for reviving fading apps, has filed for a U.S. IPO, revealing sharp revenue g...
First-quarter 2026 saw a record pace of home equity withdrawals as borrowers leaned on second liens and HELOCs rather...
Nio delivered a staggering 129% jump in EV sales, yet its stock slid in May. This analysis breaks down the drivers be...
The AI IPO race is accelerating as OpenAI joins the fray after Anthropic. This article breaks down what the filing me...
As employers rethink wellness benefits, workers weigh B12's energy promise against testing costs and coverage gaps, s...
A record-breaking bid for SpaceX could reshape the opening trading landscape. Here’s how inflows of demand influence ...
SpaceX's investor roadshow delivers a major update on capital plans and governance. Elon Musk just dealt a market-mov...
This week’s CPI data could tilt policy expectations: a hotter print may bolster a hawkish stance from the new Fed lea...
Five tech giants have issued $159 billion in corporate bonds through May 2026, eclipsing all of 2025 and signaling a ...
Cardano’s Charles Hoskinson plots a migration from X to Discord to shield the ADA community from online toxicity, sig...
In 2026, investors face the classic question of trying to beat the market or simply track it, as costs rise and fund ...
A six-pill prescription that would cost $1,000 in the United States ends up costing just $25 through an international...